EZH2 and cancer: Kim KH et al.69found that the ARID1A mutation caused cancer EZH2‐dependent proliferation with only a small portion relying on the catalytic effect of the methylation enzyme of EZH2 and most relying on the interaction of EZH2 with other proteins.